Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Non-Current Assets (2016 - 2021)

Historic Other Non-Current Assets for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $3.2 million.

  • Neurocrine Biosciences' Other Non-Current Assets fell 9925.32% to $3.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.2 million, marking a year-over-year decrease of 9925.32%. This contributed to the annual value of $6.4 million for FY2020, which is 9445.89% down from last year.
  • As of Q3 2021, Neurocrine Biosciences' Other Non-Current Assets stood at $3.2 million, which was down 9925.32% from $3.2 million recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Other Non-Current Assets peaked at $428.5 million during Q3 2020, and registered a low of $3.2 million during Q2 2021.
  • Its 5-year average for Other Non-Current Assets is $83.0 million, with a median of $5.5 million in 2018.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 900539.74% in 2020, then plummeted by 9925.32% in 2021.
  • Quarter analysis of 5 years shows Neurocrine Biosciences' Other Non-Current Assets stood at $4.5 million in 2017, then increased by 21.71% to $5.5 million in 2018, then soared by 2008.82% to $115.5 million in 2019, then plummeted by 94.46% to $6.4 million in 2020, then crashed by 50.0% to $3.2 million in 2021.
  • Its Other Non-Current Assets stands at $3.2 million for Q3 2021, versus $3.2 million for Q2 2021 and $355.8 million for Q1 2021.